Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
3,800,844
-
Share change
-
+18,659
-
Total reported value
-
$148,570,433
-
Put/Call ratio
-
68700%
-
Price per share
-
$39.09
-
Number of holders
-
75
-
Value change
-
-$692,933
-
Number of buys
-
36
-
Number of sells
-
30
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q4 2016
As of 31 Dec 2016 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,800,844 shares of stock of the company.
Largest 10 holders included UBS Group AG, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, Wharton Business Group, LLC, Psagot Investment House Ltd., BARCLAYS PLC, Baird Financial Group, Inc., WELLS FARGO & COMPANY/MN, and Hochman Cole Investment Advisors, Inc..
This table shows 75 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.